JP2007513094A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513094A5
JP2007513094A5 JP2006541751A JP2006541751A JP2007513094A5 JP 2007513094 A5 JP2007513094 A5 JP 2007513094A5 JP 2006541751 A JP2006541751 A JP 2006541751A JP 2006541751 A JP2006541751 A JP 2006541751A JP 2007513094 A5 JP2007513094 A5 JP 2007513094A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
hetaryl
benzimidazol
pyrazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513094A (ja
JP4808628B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2004/001690 external-priority patent/WO2005054230A1/en
Publication of JP2007513094A publication Critical patent/JP2007513094A/ja
Publication of JP2007513094A5 publication Critical patent/JP2007513094A5/ja
Application granted granted Critical
Publication of JP4808628B2 publication Critical patent/JP4808628B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541751A 2003-12-03 2004-12-03 アゾール系キナーゼ阻害剤 Expired - Fee Related JP4808628B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2003906686A AU2003906686A0 (en) 2003-12-03 Azole-based kinase inhibitors
AU2003906686 2003-12-03
AU2004902060 2004-04-20
AU2004902060A AU2004902060A0 (en) 2004-04-20 Azole-based kinase inhibitors (2)
PCT/AU2004/001690 WO2005054230A1 (en) 2003-12-03 2004-12-03 Azole-based kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2007513094A JP2007513094A (ja) 2007-05-24
JP2007513094A5 true JP2007513094A5 (cg-RX-API-DMAC7.html) 2007-11-15
JP4808628B2 JP4808628B2 (ja) 2011-11-02

Family

ID=34654577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541751A Expired - Fee Related JP4808628B2 (ja) 2003-12-03 2004-12-03 アゾール系キナーゼ阻害剤

Country Status (12)

Country Link
US (1) US7737143B2 (cg-RX-API-DMAC7.html)
EP (1) EP1689739B1 (cg-RX-API-DMAC7.html)
JP (1) JP4808628B2 (cg-RX-API-DMAC7.html)
KR (1) KR101211514B1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0417345A (cg-RX-API-DMAC7.html)
CA (1) CA2545425C (cg-RX-API-DMAC7.html)
ES (1) ES2578254T3 (cg-RX-API-DMAC7.html)
GB (1) GB2423083B (cg-RX-API-DMAC7.html)
IL (1) IL175568A (cg-RX-API-DMAC7.html)
NZ (1) NZ545694A (cg-RX-API-DMAC7.html)
PT (1) PT1689739T (cg-RX-API-DMAC7.html)
WO (1) WO2005054230A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642354B2 (en) 2004-04-13 2010-01-05 Icagen, Inc. Polycyclic pyrazines as potassium ion channel modulators
CA2645434A1 (en) * 2006-03-20 2007-09-27 Synta Pharmaceutical Corp. Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
JP2010505794A (ja) 2006-10-03 2010-02-25 ノイロサーチ アクティーゼルスカブ カリウムチャネル調節剤として有用なインダゾリル誘導体
GEP20125425B (en) * 2006-10-18 2012-03-26 Pfizer Prod Inc Biaryl ether urea compounds
CN101679408B (zh) 2006-12-22 2016-04-27 Astex治疗学有限公司 作为fgfr抑制剂的双环杂环化合物
US8131527B1 (en) 2006-12-22 2012-03-06 Astex Therapeutics Ltd. FGFR pharmacophore compounds
JP5442449B2 (ja) * 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド 新規化合物
UA98961C2 (uk) 2007-06-27 2012-07-10 Астразенека Аб Похідні піразинону та їх застосування у лікуванні легеневих захворювань
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
CA2723358A1 (en) * 2008-05-05 2009-11-12 Allison B. Reiss Method for improving cardiovascular risk profile of cox inhibitors
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
AU2009259853A1 (en) 2008-06-20 2009-12-23 Genentech, Inc. Triazolopyridine JAK inhibitor compounds and methods
PE20110063A1 (es) 2008-06-20 2011-02-16 Genentech Inc DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
AR073711A1 (es) 2008-10-01 2010-11-24 Astrazeneca Ab Derivados de isoquinolina
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
AR085908A1 (es) * 2011-03-16 2013-11-06 Hoffmann La Roche DERIVADOS DE 3-BUTIN-2-OL Y DE CARBONITRILO CON ACTIVIDAD INHIBIDORA DE LA QUINASA INDUCTORA DE NF-kB (NIK)
WO2014110200A1 (en) 2013-01-10 2014-07-17 Zisman Lawrence S Non-selective kinase inhibitors
ES2959419T3 (es) 2013-10-11 2024-02-26 Pulmokine Inc Formulaciones secas por aspersión
US11352328B2 (en) 2016-07-12 2022-06-07 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus
RU2763525C2 (ru) 2016-10-27 2021-12-30 Пульмокин, Инк. Комбинированная терапия для лечения легочной гипертензии
US11024307B2 (en) 2018-02-08 2021-06-01 Computime Ltd. Method and apparatus to provide comprehensive smart assistant services
US12419865B2 (en) 2018-12-06 2025-09-23 Arisan Therapeutics Inc. Compounds for the treatment of arenavirus infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2701281B2 (ja) * 1988-01-22 1998-01-21 吉富製薬株式会社 ピラゾロピリジン化合物
CA2366932C (en) * 1999-04-15 2009-08-25 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
EP1206265B1 (en) * 1999-06-30 2003-11-12 Merck & Co., Inc. Src kinase inhibitor compounds
WO2002060492A1 (en) 2001-01-30 2002-08-08 Cytopia Pty Ltd Methods of inhibiting kinases
ATE457025T1 (de) 2002-05-23 2010-02-15 Cytopia Res Pty Ltd Kinaseinhibitoren
AUPS251402A0 (en) * 2002-05-23 2002-06-13 Cytopia Pty Ltd Kinase inhibitors
ES2389203T3 (es) * 2004-01-12 2012-10-24 Ym Biosciences Australia Pty Ltd Inhibidores de quinasa selectivos

Similar Documents

Publication Publication Date Title
JP7696443B2 (ja) Egfr変異を有するがんを処置するためのアミノ置換ヘテロ環類
CN104203952B (zh) 咪唑并吡咯烷酮化合物
JP2007517807A5 (cg-RX-API-DMAC7.html)
JP5911638B2 (ja) ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用
CA2651363A1 (en) Triazolopyrazine derivatives useful as anti-cancer agents
JP2016522246A5 (cg-RX-API-DMAC7.html)
HRP20240861T1 (hr) Derivati 6-(4-amino-3-metil-2-oksa-8-azaspiro[4.5]dekan-8-il)-3-(2,3-dihlorofenil)-2-metilpirimidin-4(3h)-ona i srodni spojevi kao inhibitori ptpn11 (shp2) za liječenje raka
JP2019534260A5 (cg-RX-API-DMAC7.html)
JP2012501312A5 (cg-RX-API-DMAC7.html)
JP2016537384A5 (cg-RX-API-DMAC7.html)
PE20070004A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
JP2014526500A5 (cg-RX-API-DMAC7.html)
JP2009536620A5 (cg-RX-API-DMAC7.html)
JP2012520867A5 (cg-RX-API-DMAC7.html)
JP2015517566A5 (cg-RX-API-DMAC7.html)
RU2006136881A (ru) Фармацевтическая композиция, содержащая производное бензодиазепина и ингибитор белка слияния rsv
RU2005117383A (ru) Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета
KR20180054657A (ko) Dna 손상제 및 atr 저해제의 병용물을 사용한 암 치료 방법
JP2009538897A5 (cg-RX-API-DMAC7.html)
JP2008528469A5 (cg-RX-API-DMAC7.html)
JP2017528487A5 (cg-RX-API-DMAC7.html)
RU2015154676A (ru) Соединения для лечения спинальной мышечной атрофии
RU2010150786A (ru) Пирролопиридины как ингибиторы киназы
JP2007528379A5 (cg-RX-API-DMAC7.html)
AU2004262897B9 (en) Combination of mGluR2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders